BG MEDICINE, INC. Research and Development Expense
BG MEDICINE, INC. reported Research and Development Expense of $1.77 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-04-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2016-04-04
- BG MEDICINE, INC. research and development expense for the quarter ending 2015-12-31 was $460.00K, a 14.50% decline year-over-year.
- BG MEDICINE, INC. research and development expense for the quarter ending 2015-09-30 was $333.00K, a 54.01% decline year-over-year.
- BG MEDICINE, INC. research and development expense for the quarter ending 2015-06-30 was $498.00K, a 13.09% decline year-over-year.
- BG MEDICINE, INC. research and development expense for the quarter ending 2015-03-31 was $483.00K, a 13.75% decline year-over-year.
- BG MEDICINE, INC. research and development expense for fiscal 2015 was $1.77M, a 25.87% decline from fiscal 2014.
- BG MEDICINE, INC. research and development expense for fiscal 2014 was $2.39M, a 35.93% decline from fiscal 2013.
- BG MEDICINE, INC. research and development expense for fiscal 2013 was $3.73M, a 50.74% decline from fiscal 2012.
- BG MEDICINE, INC. research and development expense for fiscal 2012 was $7.58M, a 5.20% decline from fiscal 2011.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2015-12-31 | $460.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-04 | $793.00K derived: sum of 2 quarters · filed 2016-04-04 | $1.29M derived: sum of 3 quarters · filed 2016-04-04 | $1.77M 10-K · filed 2016-04-04 |
| 2015-09-30 | $333.00K 10-Q · filed 2015-11-16 | $831.00K derived: sum of 2 quarters · filed 2015-11-16 | $1.31M 10-Q · filed 2015-11-16 | $1.85M derived: sum of 4 quarters · filed 2016-04-04 |
| 2015-06-30 | $498.00K 10-Q/A · filed 2015-08-18 | $981.00K 10-Q/A · filed 2015-08-18 | $1.52M derived: sum of 3 quarters · filed 2016-04-04 | $2.24M derived: sum of 4 quarters · filed 2016-04-04 |
| 2015-03-31 | $483.00K 10-Q · filed 2015-05-15 | $1.02M derived: sum of 2 quarters · filed 2016-04-04 | $1.75M derived: sum of 3 quarters · filed 2016-04-04 | $2.32M derived: sum of 4 quarters · filed 2016-04-04 |
| 2014-12-31 | $538.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-04 | $1.26M derived: sum of 2 quarters · filed 2016-04-04 | $1.83M derived: sum of 3 quarters · filed 2016-04-04 | $2.39M 10-K · filed 2016-04-04 |
| 2014-09-30 | $724.00K 10-Q · filed 2015-11-16 | $1.30M derived: sum of 2 quarters · filed 2015-11-16 | $1.85M 10-Q · filed 2015-11-16 | $2.05M derived: sum of 4 quarters · filed 2016-04-04 |
| 2014-06-30 | $573.00K 10-Q/A · filed 2015-08-18 | $1.13M 10-Q/A · filed 2015-08-18 | $1.33M derived: sum of 3 quarters · filed 2016-04-04 | $2.38M derived: sum of 4 quarters · filed 2016-04-04 |
| 2014-03-31 | $560.00K 10-Q · filed 2015-05-15 | $754.00K derived: sum of 2 quarters · filed 2016-04-04 | $1.80M derived: sum of 3 quarters · filed 2016-04-04 | $2.92M derived: sum of 4 quarters · filed 2016-04-04 |
| 2013-12-31 | $194.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-04 | $1.24M derived: sum of 2 quarters · filed 2016-04-04 | $2.36M derived: sum of 3 quarters · filed 2016-04-04 | $3.73M 10-K · filed 2016-04-04 |
| 2013-09-30 | $1.05M 10-Q · filed 2014-11-14 | $2.17M derived: sum of 2 quarters · filed 2014-11-14 | $3.54M 10-Q · filed 2014-11-14 | $3.46M derived: sum of 4 quarters · filed 2015-03-31 |
| 2013-06-30 | $1.12M 10-Q · filed 2014-08-14 | $2.49M 10-Q · filed 2014-08-14 | $2.41M derived: sum of 3 quarters · filed 2015-03-31 | $4.96M derived: sum of 4 quarters · filed 2015-03-31 |
| 2013-03-31 | $1.38M 10-Q · filed 2014-05-14 | $1.30M derived: sum of 2 quarters · filed 2015-03-31 | $3.85M derived: sum of 3 quarters · filed 2015-03-31 | $5.98M derived: sum of 4 quarters · filed 2015-03-31 |
| 2012-12-31 | -$80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $2.47M derived: sum of 2 quarters · filed 2015-03-31 | $4.60M derived: sum of 3 quarters · filed 2015-03-31 | $7.58M 10-K · filed 2015-03-31 |
| 2012-09-30 | $2.55M 10-Q · filed 2013-11-06 | $4.68M derived: sum of 2 quarters · filed 2013-11-06 | $7.66M 10-Q · filed 2013-11-06 | $9.65M derived: sum of 4 quarters · filed 2014-03-27 |
| 2012-06-30 | $2.13M 10-Q · filed 2013-08-09 | $5.11M 10-Q · filed 2013-08-09 | $7.10M derived: sum of 3 quarters · filed 2014-03-27 | $9.04M derived: sum of 4 quarters · filed 2014-03-27 |
| 2012-03-31 | $2.98M 10-Q · filed 2013-05-10 | $4.97M derived: sum of 2 quarters · filed 2014-03-27 | $6.90M derived: sum of 3 quarters · filed 2014-03-27 | $9.27M derived: sum of 4 quarters · filed 2014-03-27 |
| 2011-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $3.92M derived: sum of 2 quarters · filed 2014-03-27 | $6.29M derived: sum of 3 quarters · filed 2014-03-27 | $8.00M 10-K · filed 2014-03-27 |
| 2011-09-30 | $1.94M 10-Q · filed 2012-11-13 | $4.30M derived: sum of 2 quarters · filed 2012-11-13 | $6.01M 10-Q · filed 2012-11-13 | $6.95M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $2.36M 10-Q · filed 2012-08-09 | $4.07M 10-Q · filed 2012-08-09 | $5.02M derived: sum of 3 quarters · filed 2013-03-18 | $6.70M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $1.71M 10-Q · filed 2012-05-15 | $2.66M derived: sum of 2 quarters · filed 2013-03-18 | $4.34M derived: sum of 3 quarters · filed 2013-03-18 | $5.88M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | $943.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $2.62M derived: sum of 2 quarters · filed 2013-03-18 | $4.17M derived: sum of 3 quarters · filed 2013-03-18 | $6.54M 10-K · filed 2013-03-18 |
| 2010-09-30 | $1.68M 10-Q · filed 2011-11-07 | $3.22M derived: sum of 2 quarters · filed 2011-11-07 | $5.60M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $1.54M 10-Q · filed 2011-08-11 | $3.92M 10-Q · filed 2011-08-11 | ||
| 2009-12-31 | $8.53M 10-K · filed 2012-03-30 |